GJB2 and hearing loss disorder: Its use in genetically heterogeneous conditions, such as hearing loss, is effective in molecular investigation, and it is recommended for all subjects after screening for variants in the DFNB1 locus, with normal results (Alford et al., 2014; Wright, Fitzpatrick, Firth, 2018).